Murchinson’s Acumen Pharmaceuticals ABOS Stock Holding History

Murchinson’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-56,250	Closed	-$136K	–	82
2024 Q2	$136K	Buy	+56,250	New	+$179K	0.02%	58

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Murchinson's ABOS Position: Q3 2024 in Review

Murchinson sold out of Acumen Pharmaceuticals (ABOS) in Q3 2024, closing a stake of 56,250 shares — an estimated $136K sold.

Murchinson first reported a position in ABOS in Q2 2024 and held it in 1 quarter. The position peaked at $136K in Q2 2024. 73 funds tracked by Wall St. Rank hold ABOS as of Q3 2024.

Murchinson reported no remaining Acumen Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Murchinson sold 56,250 Acumen Pharmaceuticals shares in Q3 2024, an estimated $136K.
Murchinson first reported a position in Acumen Pharmaceuticals in Q2 2024 and held it in 1 quarter.
Murchinson's Acumen Pharmaceuticals position peaked at $136K in Q2 2024.
73 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2024.

Based on Murchinson's 13F filing for Q3 2024, filed 14 Nov 2024.